Summary
Silent myocardial ischaemia (significant ST depression without chest pain) is a common occurrence in most forms of coronary heart disease and can be associated with permanent changes in myocardial structure. The haemodynamic and ECG manifestations of silent episodes are similar to those observed in painful ischaemia.
Exercise testing is the most appropriate method for assessing the severity of coronary artery disease; increased sensitivity can be obtained by combining it with radionuclide scintigraphy or ventriculography. Ambulatory ECG monitoring may fail to detect ischaemic changes revealed by exercise provocation.
The treatment approach should depend on the degree of ischaemia. Numerous clinical investigations in stable and unstable angina and in patients with a previous myocardial infarction indicate that the prognosis of patients with myocardial ischaemia does not depend on whether the ischaemia is silent or symptomatic. Silent and symptomatic episodes alone represent the same degree of coronary disease. Moreover, it appears that ischaemic episodes are a more powerful adverse prognostic influence than left ventricular function or the extent of coronary artery disease.
All anti-ischaemic agents, such as β-blockers, calcium antagonists and nitrates, and interventions such as coronary balloon angioplasty or coronary bypass surgery, are very effective treatments for myocardial ischaemia. All efforts should be made to prevent ischaemic episodes, whether silent or symptomatic, since the severity of disease rather than the presence or absence of symptoms more accurately reflects the need for intervention.
Similar content being viewed by others
References
Amsterdam EA. Relation of silent myocardial ischemia to ventricular arrhythmias and sudden death. American Journal of Cardiology 62: 241–271, 1988
Banai S, Stern S, Tzivoni D. Effect of nisoldipine on myocardial ischemia: evaluation of Hoher monitoring. In Hugenholtz PG and Meyer J (Eds) Nisoldipine, pp. 276–281, Springer-Verlag, Berlin, 1987
Beller G. Myocardial perfusion imaging for detection of silent myocardial ischemia. American Journal of Cardiology 61: 22F–26F, 1988
Berman DS, Rozanski A, Knoebel SB. The detection of silent ischemia: cautions and precautions. Circulation 75: 101–105, 1987
Callaham P, Dubach P, Klein J, Rish M, Froelicher V. Prognostic significance of silent myocardial ischemia discovered during exercise testing. Journal of the American College of Cardiology 11: 24, 1988
Cohn PF, Lawson WE, Gennaro V, Brady D. Effect of nifedipine on out of hospital silent myocardial ischemia in asymptomatic men with coronary artery disease. American Journal of Cardiology 61: 908–910, 1988
Davies GJ, Bencivelli W, Fragasso G, Chierchia S, Crea F, et al. Sequence and magnitude of ventricular volume changes in painful and painless myocardial ischemia. Circulation 78: 310–319, 1988
Deanfield JE, Shea M, Ribiero P, De Landsheere CM, Wilson RA, et al. Transient ST segment depression as a marker of myocardial ischemia during daily life. American Journal of Cardiology 54: 1195–1200, 1984
DeBoer FWV, Ingwall JS, Kloner RA, Braunwald E. Prolonged derangements of canine myocardial purine metabolism after a brief coronary occlusion not associated with anatomic evidence of necrosis. Proceedings of the National Academy of the Sciences of the United States of America 77: 547–555, 1980
Deedwania P, Carbajal E. Prevalence and patterns of silent myocardial ischemia during daily life in stable angina patients receiving conventional antianginal drug therapy. American Journal of Cardiology 65: 1090–1096, 1990b
Deedwania P, Carbajal E. Silent ischemia during daily life is an independent predictor of mortality in stable angina. Circulation 81: 748–756, 1990a
Falcone C, Servi S, Poma E, Campana C, Scire A, et al. Clinical significance of exercise-induced silent myocardial ischemia in patients with coronary artery disease. Journal of the American College of Cardiology 9: 295–299, 1987
Garan H, Ruskin JN, DiMarco JP, Derkac WM, et al. Electro physiologic studies before and after myocardial revascularisation in patients with life threatening ventricular arrhythmias. American Journal of Cardiology 51: 519–524, 1983
Gasperetti C, Burwell L, Beller G. Prevalence of and variables associated with silent myocardial ischemia on exercise thallium-201 stress testing. Journal of the American College of Cardiology 16: 115–123, 1990
Geft IL, Fishbein MC, Ninomiya K, Hashida J, Chauxe Yano J, et al. Intermittent brief periods of ischemia have a cumulative effect and may cause myocardial necrosis. Circulation 66: 1150–1153, 1982
Gottlieb SO, Weisfeldt ML, Ouyang P, Mellits DE, Gerstenblith G. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. New England Journal of Medicine 314: 1214–1219, 1986
Gottlieb SO, Weisfeldt ML, Ouyang P, Mellits ED, Gerstenblith G. Silent ischemia predicts infarction and death during 2 year follow-up of unstable angina. Journal of the American College of Cardiology 10: 756–760, 1987
Gradman AH, Bell PA, DeBusk RF. Sudden death during ambulatory monitoring: clinical and electrocardiographic correlations: report of a case. Circulation 55: 210–211, 1977
Hausmann D, Nikutta P, Trappe H, Daniel W, Wenzlaff P, et al. Incidence of ventricular arrhythmias during transient myocardial ischemia in patients with stable coronary artery disease. Journal of the American College of Cardiology 16: 49–54, 1990
Hess OM, Schneider J, Nonogi H, Carroll J, Schneider K, et al. Myocardial structure in patients with exercise induced ischemia. Circulation 77: 967–977, 1988
Heyndrickx GR, Miliard RW, McRitchie RJ, Maroko PR, Vatner SF. Regional myocardial function and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. Journal of Clinical Investigation 56: 978–985, 1975
Hirzel HO, Leutwyler R, Krayenbuehl HP. Silent myocardial ischemia: hemodynamic changes during dynamic exercise in patients with proven coronary artery disease despite absence of angina pectoris. Journal of the American College of Cardiology 6: 275–284, 1985
Jennings RB. Early phase of myocardial ischemic injury and infarction. American Journal of Cardiology 24: 753–765, 1969
Josephson MA, Nademanee K, Intarachot V, Lewis H, Singh B. Abolition of Holter monitor detected silent myocardial ischemia after percutaneous transluminal coronary angioplasty. Journal of the American College of Cardiology 10: 499–503, 1987
Khurmi NS, Bowles MJ, O’Hara MJ. Effect of propranolol onindices of intermittent myocardial ischemia, assessed by exercise testing and ambulatory ST segment monitoring. Clinical Cardiology 9: 391–397, 1986
Levy RD, Shapiro LM, Wright C, Mockus L, Fox K. The haemodynamic significance of asymptomatic ST segment depression assessed by ambulatory pulmonary artery pressure monitoring. British Heart Journal 56: 526–530, 1986
Morady F, DiCarlo LA, Krol RB, Annesley TM, O’Neill WM, et al. Role of myocardial ischemia during programmed stimulation in survivors of cardiac arrest with coronary artery disease. Journal of the American College of Cardiology 9: 1004–1012, 1987
Nademanee K, Intarachot V, Josephson MA, Rieders D, Mody FV, et al. Prognostic significance of silent myocardial ischemia in patients with unstable angina. Journal of the American College of Cardiology 10: 1–9, 1987a
Nademanee K, Intarachot V, Josephson MA, Singh BN. Circadian variation in occurrence of transient overt and silent myocardial ischemia in chronic stable angina and comparison with Prinzmetal angina in men. American Journal of Cardiology 60: 494–498, 1987b
Ouyang P, Shapiro E, Chandra NC, Gottlieb S, Chew P, et al. An angiographic and functional comparison of patients with silent and symptomatic treadmill ischemia early after myocardial infarction. American Journal of Cardiology 59: 730–734, 1987
Quyyumi AA, Wright CM, Mockus LJ, Fox KM. Effect of partial agonist activity in beta-blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol. British Medical Journal 289: 951–953, 1984
Rocco MB, Nabel EG, Campbell S, Goldman M, Barry J, et al. Prognostic importance of myocardial ischemia detected by ambulatory monitoring in patients with stable coronary artery disease. Circulation 78: 877–884, 1988
Schang SJ, Pepine CJ. Transient asymptomatic ST segment depression during daily activity. American Journal of Cardiology 39: 396–402, 1977
Shell WE. Mechanism and therapy of silent myocardial ischemia and the effects of transdermal nitroglycerine. American Journal of Cardiology 56: 231–271, 1985
Stern S, Banai S, Keren A, Tzivoni D. Ventricular ectopic activity during myocardial ischemic episodes in ambulatory patients. American Journal of Cardiology 65: 412–416, 1990
Stern S, Gavish A, Weisz G, Benhorin J, Keren A, et al. Characteristics of silent and symptomatic myocardial ischemia during daily activities. American Journal of Cardiology 61: 1223–1228, 1988
Stern S, Tzivoni D. Early detection of silent ischemic heart disease by 24-hour electrocardiographic monitoring of active subjects. British Heart Journal 36: 481–486, 1974
Stern S, Tzivoni D, Stern Z. Diagnostic accuracy of ambulatory ECG monitoring in ischemic heart disease. Circulation 52: 1045–1049, 1975
Theroux P, Ross J, Franklin D, Kemper W, Sasayama S. Coronary arterial reperfusion III. Early and late effects on regional myocardial function and dimension in conscious dogs. American Journal of Cardiology 38: 599–606, 1976
Tzivoni D, Benhorin J, Gavish A, Stern S. Holter recording during treadmill testing in assessing myocardial ischemic changes. American Journal of Cardiology 55: 1200–1203, 1985
Tzivoni D, Gavish A, Benhorin J, Keren A, Stern S. Myocardial ischemia during daily activities and stress. American Journal of Cardiology 58: 47b–50b, 1986
Tzivoni D, Gavish D, Zin D, Gottlieb S, Moriel M, et al. Prognostic significance of ischemic episodes in patients with previous myocardial infarction. American Journal of Cardiology 62: 661–664, 1988
Tzivoni D, Weisz G, Gavish A, Zin D, Keren A, et al. Comparison of mortality and myocardial infarction rates in stable angina pectoris with and without ischemic episodes during daily activities. American Journal of Cardiology 63: 273–276, 1989
Von Arnim T, Erath A. Nitrates and calcium antagonists for silent myocardial ischemia. American Journal of Cardiology 61: 15E–18E, 1988
Von Arnim T, Höfling B, Schreiber M. Characteristics of episodes of ST elevation or ST depression during ambulatory monitoring in patients subsequently undergoing coronary angiography. British Heart Journal 54: 484–488, 1985
Weiner DA, Ryan T, McCabe C, Grace N, Chaitman B, et al. Risk of developing an acute myocardial infarction or sudden coronary death in patients with exercise-induced silent myocardial ischemia. A report from the coronary artery surgery study (CASS) registry. American Journal of Cardiology 62: 1155–1158, 1988
Wilcox I, Freedman B, Kelly D, Harris P. Clinical significance of silent ischemia in unstable angina pectoris. American Journal of Cardiology 65: 1313–1316, 1990
Wohlgelernter D, Jaffe CC, Cabin HS, Yeatman LA, Cleman M. Silent ischemia during coronary occlusion produced by balloon inflation: relation to regional myocardial dysfunction. Journal of the American College of Cardiology 10: 491–498, 1987
Wolf E, Tzivoni D, Stern S. Comparison of exercise test and 24-hour ambulatory electrocardiographic monitoring in detection of ST-T changes. British Heart Journal 36: 90–95, 1974
Zhao M, Zhang H, Robinson TF, Factor SM, Sonnenblick EH, et al. Profound structural alterations of the extracellular collagen matrix in postischemic dysfunctional (‘stunned’) but viable myocardium. Journal of the American College of Cardiology 10: 1322–1334, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tzivoni, D. Silent Ischaemia in the 1990s. Drugs 42 (Suppl 1), 51–57 (1991). https://doi.org/10.2165/00003495-199100421-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199100421-00010